首页 > 市场调查报告书 > 医疗设备

手术用器具泌尿科

市场调查报告书

商品编码

1560817

全球碎石机设备市场 - 2024 - 2031

Global Lithotripter Devices Market - 2024 - 2031

出版日期: 2024年09月23日 | 出版商:

DataM Intelligence | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

报告概述

全球碎石机设备市场在 2023 年达到 11.5 亿美元，预计到 2031 年将达到 18.7 亿美元，2024-2031 年预测期间复合年增长率为 6.3%。

碎石机是一种用于治疗肾结石和泌尿道内其他结石（结石）的医疗设备。它的工作原理是产生衝击波，将结石破碎成更小的碎片，使它们更容易透过排尿排出。碎石机的主要类型包括体外震波碎石（ESWL）装置和体内碎石装置。

ESWL 设备在体外产生衝击波，利用 X 射线或超音波等成像技术将衝击波定向到结石的位置。衝击波穿透身体并碎石，无需手术干预。 ESWL 被认为是治疗肾结石最常见且侵入性最小的方法。

体内碎石装置直接插入体内以碎石。他们利用各种能源，包括雷射、电动液压、机械或超音波能量来破碎石头。当 ESWL 不适合时，例如涉及输尿管结石或难以通过 ESWL 碎裂的结石时，通常会使用体内碎石术。

市场动态：

司机

尿路结石发生率增加及技术进步

全球碎石设备市场的需求是由多种因素所驱动的。主要因素之一是尿路结石发生率的增加和技术的进步。肾结石和相关尿路结石盛行率的上升是碎石设备需求的主要驱动力。碎石技术的持续创新正在显着提高治疗效果并推动市场成长。

这些进步的重点是开发更有效、更安全的设备，以解决临床疗效和病人安全问题。突发波碎石术 (BWL) 和高频衝击波等创新代表了肾结石治疗的重大进步，提高了碎石的有效性和手术的安全性。

此外，该行业的主要参与者产品发布和关键开发将推动该市场的成长。例如，2024 年 5 月，多尼尔医疗科技推出了 UroGPT，这是第一个专门用于帮助患者处理肾结石的人工智慧工具。这项创新应用程式旨在透过提供与肾结石管理相关的可靠、按需资讯和可行的见解来加强患者护理。

此外，波士顿科学公司还计划于 2024 年 3 月透过其采用先进 MOSES 2.0 技术的 Lumenis Pulse 120H 钬雷射系统支援韩国的肾结石治疗。该系统旨在提高碎石术的效率和效果，这对于治疗尿路结石症或肾结石至关重要。

限制

替代治疗方案的可用性以及碎石设备相关的不良反应等因素预计将阻碍市场。

细分市场分析

全球碎石设备市场根据类型、应用、最终用户和地区进行细分。

体外震波碎石设备 (ESWL) 领域约占全球碎石设备市场份额的 72%

体外震波碎石设备（ESWL）领域预计将在预测期内占据最大的市场份额。体外震波碎石术（ESWL）是一种非侵入性医疗技术，主要用于治疗肾结石。此手术使用衝击波将结石破碎成小块，使它们更容易通过尿道。 ESWL 因其有效性和与传统手术方法相比可缩短恢復时间而成为首选。

此外，政府的倡议和支持、金融投资和关键发展将推动该市场的成长。例如，2023 年 6 月，Barking、Havering 和 Redbridge University Hospitals NHS Trust 旗下的乔治国王医院在减少泌尿科择期手术积压方面面临挑战。为了解决这个问题，该医院投资了一台新的体外震波碎石机（ESWL），以更有效地治疗肾结石患者。

同样，2023 年 5 月，卫生部长马云。 Subramanian 在政府 Kilpauk 医学院 (KMC) 医院开设了体外震波碎石术 (ESWL) 治疗中心。这台 ESWL 机器由摩比斯印度基金会透过其企业社会责任计画资助，耗资 23 亿卢比。

市场地域占有率

北美约占全球碎石设备市场份额的44.6%

由于肾结石发病率的增加是推动北美碎石设备市场的主要因素，预计北美地区将在预测期内占据最大的市场份额。这种不断上升的盛行率对有效的治疗解决方案产生了更大的需求，例如碎石术，它因其非侵入性的肾结石治疗方法而受到青睐。

患者偏好转向微创和非侵入性手术是现代医疗保健的重要趋势，特别是在肾结石碎石术方面。碎石技术的不断进步，特别是更有效率、更安全的设备的创造，正在改善治疗效果。突发波碎石术和高频衝击波等创新技术可以更准确地定位肾结石，从而降低邻近组织受损的风险。

此外，大量关键参与者的存在、先进的医疗基础设施、产品发布和批准以及政府措施有助于推动该市场的成长。例如，2024 年 3 月，Calyxo Inc. 重新设计的 CVAC（连续真空抽吸导管）系统获得 FDA 批准，该系统专门用于在雷射碎石手术后收集肾结石碎片。这种创新设备旨在透过最大限度地减少可能导致併发症的残余结石负担来提高肾结石治疗的有效性。

同样，2024年5月，Huons Meditech在德克萨斯州举行的美国泌尿外科协会（AUA）2024年会议上展示了其电磁衝击波碎石机ASADAL-M1。该活动是全球最负盛名的泌尿外科会议之一，吸引了领先的泌尿科医生和医疗保健专业人士讨论该领域的创新和进步。

A lithotripter is a medical device utilized for the treatment of kidney stones and other calculi (stones) within the urinary tract. It operates by generating shock waves that break the stones into smaller fragments, allowing them to be more easily expelled through urination. The primary types of lithotripters include extracorporeal shock wave lithotripsy (ESWL) devices and intracorporeal lithotripsy devices.

ESWL devices produce shock waves outside the body, which are directed at the location of the stones using imaging techniques such as X-ray or ultrasound. The shock waves penetrate the body and fragment the stones without the need for surgical intervention. ESWL is recognized as the most common and least invasive method for treating kidney stones.

Intracorporeal lithotripsy devices are inserted directly into the body to break up stones. They employ various energy sources, including laser, electrohydraulic, mechanical, or ultrasonic energy, to fragment the stones. Intracorporeal lithotripsy is typically used when ESWL is not suitable, such as in cases involving stones located in the ureter or those that resist fragmentation through ESWL.

Market Dynamics: Drivers

Increasing incidence of urolithiasis and technological advancements

The demand for the global lithotripter devices market is driven by multiple factors. One of the primary factors is the increasing incidence of urolithiasis and technological advancements. The rising prevalence of kidney stones and related urolithiasis conditions is a primary driver for the demand for lithotripsy devices. Continuous innovations in lithotripsy technology are significantly enhancing treatment outcomes and driving market growth.

These advancements focus on developing more effective and safer devices, that address both clinical efficacy and patient safety. Innovations such as burst wave lithotripsy (BWL) and high-frequency shock waves represent significant advancements in the treatment of kidney stones, enhancing both the effectiveness of stone fragmentation and the safety of the procedure.

Moreover, key players in the industry product launches and key developments that would propel this market growth. For instance, in May 2024, Dornier MedTech launched UroGPT, the first artificial intelligence tool specifically designed to assist patients dealing with kidney stones. This innovative application aims to enhance patient care by providing reliable, on-demand information and actionable insights related to kidney stone management.

Also, in March 2024, Boston Scientific is set to support kidney stone treatment in South Korea with its Lumenis Pulse 120H Holmium Laser System, which incorporates the advanced MOSES 2.0 technology. This system is designed to enhance the efficiency and effectiveness of lithotripsy procedures, which are critical for managing urolithiasis, or kidney stones.

Restraints

Factors such as the availability of alternative treatment options, and adverse effects associated with lithotripsy devices are expected to hamper the market.

Market Segment Analysis

The global lithotripter devices market is segmented based on type, application, end-user, and region.

The extracorporeal shock wave lithotripsy devices (ESWL) segment accounted for approximately 72% of the global lithotripter devices market share

The extracorporeal shock wave lithotripsy devices (ESWL) segment is expected to hold the largest market share over the forecast period. Extracorporeal Shock Wave Lithotripsy (ESWL) is a non-invasive medical technique primarily utilized for the treatment of kidney stones. This procedure uses shock waves to fragment the stones into smaller pieces, making it easier for them to be passed through the urinary tract. ESWL is preferred due to its effectiveness and the reduced recovery time it offers in comparison to conventional surgical methods.

Moreover, government initiatives & support, financial investments, and key developments would propel this market growth. For instance, in June 2023, King George Hospital, part of Barking, Havering, and Redbridge University Hospitals NHS Trust, faced challenges in reducing the elective surgery backlog in its urology department. To address this, the hospital invested in a new Extracorporeal Shock Wave Lithotripsy (ESWL) machine to treat patients with kidney stones more efficiently.

Similarly, in May 2023, Health Minister Ma. Subramanian inaugurated an Extracorporeal Shock Wave Lithotripsy (ESWL) Treatment Centre at the Government Kilpauk Medical College (KMC) Hospital. The ESWL machine, which was funded by the MOBIS India Foundation through its corporate social responsibility initiatives, costs ₹2.3 crore.

Market Geographical Share

North America accounted for approximately 44.6% of the global lithotripter devices market share

North America region is expected to hold the largest market share over the forecast period owing to the increasing occurrence of kidney stones is a major factor driving the lithotripsy device market in North America. This rising prevalence creates a greater need for effective treatment solutions, such as lithotripsy, which is favored for its non-invasive approach to managing kidney stones.

The shift in patient preference towards minimally invasive and non-invasive procedures is a significant trend in modern healthcare, particularly in the context of lithotripsy for kidney stones. Ongoing advancements in lithotripsy technology, particularly the creation of more efficient and safer devices, are improving treatment results. Innovations like burst wave lithotripsy and high-frequency shock waves enable more accurate targeting of kidney stones, reducing the risk of damage to adjacent tissues.

Moreover, a major number of key players' presence, well-advanced healthcare infrastructure, product launches & approvals, and government initiatives help to drive this market growth. For instance, in March 2024, Calyxo Inc. received FDA approval for its redesigned CVAC (Continuous Vacuum Aspiration Catheter) system, which is specifically designed to collect kidney stone fragments following laser lithotripsy procedures. This innovative device aims to enhance the effectiveness of kidney stone treatments by minimizing the residual stone burden that can lead to complications.

Similarly, in May 2024, Huons Meditech showcased its electromagnetic shock wave lithotripter, the ASADAL-M1, at the American Urological Association (AUA) 2024 Conference held in Texas. This event is one of the most prestigious urological conferences globally, attracting leading urologists and healthcare professionals to discuss innovations and advancements in the field.

Market Segmentation

By Type

Extracorporeal Shock Wave Lithotripsy Devices (ESWL)

Intracorporeal Lithotripsy Devices

Mechanical Lithotripsy

Electrohydraulic Lithotripsy (EHL)

Laser Lithotripsy

Ultrasonic Lithotripsy

By Application

Kidney Stones

Ureteral Stones

Pancreatic Stones

Bile Duct Stones

By End-User

Hospitals

Specialty Clinics

Ambulatory Surgical Centers

By Region

North America

U.S.

Canada

Mexico

Europe

Germany

U.K.

France

Spain

Italy

Rest of Europe

South America

Brazil

Argentina

The rest of South America

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific

Middle East and Africa

Market Competitive Landscape

The major global players in the lithotripter devices market include Boston Scientific Corporation, EDAP TMS, Richard Wolf GmbH, Olympus, Cook, Dornier MedTech., DirexGroup, STORZ MEDICAL AG, KARL STORZ, and ELMED Medical Systems among others

Key Developments

In February 2023, Rhein Laser introduced the UroFiber 150Q system, a cutting-edge SuperPulsed thulium fiber laser (TFL) technology designed to enhance treatments for stone lithotripsy and benign prostatic hyperplasia (BPH) enucleation. This system is notable for being the world's first 150W SuperPulsed TFL system, which allows for more effective and efficient procedures in urology.

Why Purchase the Report?

To visualize the global lithotripter devices market segmentation based on type, application, end-user, and region and understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development.

Excel data sheet with numerous data points on the lithotripter devices market in all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping is available in excel consisting of key products of all the major players.

The global lithotripter devices market report would provide approximately 62 tables, 52 figures, and 183 pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Type
3.2. Snippet by Application
3.3. Snippet by End-User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing Incidence of Urolithiasis and Technological Advancements
- 4.1.2. Restraints
  - 4.1.2.1. Availability of Alternative Treatment Options
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. By Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 6.1.2. Market Attractiveness Index, By Type
6.2. Extracorporeal Shock Wave Lithotripsy Devices (ESWL) *
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Intracorporeal Lithotripsy Devices
- 6.3.1. Mechanical Lithotripsy
- 6.3.2. Electrohydraulic Lithotripsy (EHL)
- 6.3.3. Laser Lithotripsy
- 6.3.4. Ultrasonic Lithotripsy

7. By Application

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 7.1.2. Market Attractiveness Index, By Application
7.2. Kidney Stones *
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Ureteral Stones
7.4. Pancreatic Stones
7.5. Bile Duct Stones

8. By End-User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 8.1.2. Market Attractiveness Index, By End-User
8.2. Hospitals *
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Specialty Clinics
8.4. Ambulatory Surgical Centers

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. U.S.
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. U.K.
  - 9.3.6.3. France
  - 9.3.6.4. Spain
  - 9.3.6.5. Italy
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. South Korea
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. Boston Scientific Corporation*
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. EDAP TMS
11.3. Richard Wolf GmbH
11.4. Olympus
11.5. Cook
11.6. Dornier MedTech.
11.7. DirexGroup
11.8. STORZ MEDICAL AG,
11.9. KARL STORZ
11.10. ELMED Medical Systems. (*LIST NOT EXHAUSTIVE)